Larotrectinib before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?

Steven G. Waguespack; Sanjit O. Tewari; Naifa L. Busaidy; Mark E. Zafereo

doi:10.1200/PO.21.00467

Larotrectinib before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?

Steven G. Waguespack, Sanjit O. Tewari, Naifa L. Busaidy, Mark E. Zafereo

Endocrine Neoplasia & HD

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Original language	English (US)
Article number	e2100467
Journal	JCO Precision Oncology
Volume	6
DOIs	https://doi.org/10.1200/PO.21.00467
State	Published - Apr 1 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/PO.21.00467

Cite this

Larotrectinib before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease? / Waguespack, Steven G.; Tewari, Sanjit O.; Busaidy, Naifa L. et al.
In: JCO Precision Oncology, Vol. 6, e2100467, 01.04.2022.

Research output: Contribution to journal › Article › peer-review

@article{5c452095daaf4bcb9de842a455f6355b,

title = "Larotrectinib before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?",

author = "Waguespack, {Steven G.} and Tewari, {Sanjit O.} and Busaidy, {Naifa L.} and Zafereo, {Mark E.}",

year = "2022",

month = apr,

day = "1",

doi = "10.1200/PO.21.00467",

language = "English (US)",

volume = "6",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Larotrectinib before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma

T2 - Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?

AU - Waguespack, Steven G.

AU - Tewari, Sanjit O.

AU - Busaidy, Naifa L.

AU - Zafereo, Mark E.

PY - 2022/4/1

Y1 - 2022/4/1

UR - http://www.scopus.com/inward/record.url?scp=85131841902&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85131841902&partnerID=8YFLogxK

U2 - 10.1200/PO.21.00467

DO - 10.1200/PO.21.00467

M3 - Article

C2 - 35420905

AN - SCOPUS:85131841902

SN - 2473-4284

VL - 6

JO - JCO Precision Oncology

JF - JCO Precision Oncology

M1 - e2100467

ER -

Larotrectinib before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion-Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metastatic Disease?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this